deltatrials
Terminated PHASE4 INTERVENTIONAL 2-arm NCT01890694

Tolvaptan to Reduce Length of Stay in Hospitalized Patients With Cirrhosis and Hyponatremia

Sponsor: NYU Langone Health

Conditions Hyponatremia
Interventions Ascites Evaluation Blood laboratory tests Edema Hepatic Encephalopathy Assessment Placebo Quality of Life Assessment Tolvaptan Vital signs
Updated 10 times since 2017 Last updated: Nov 8, 2017 Started: Mar 31, 2012 Primary completion: Mar 31, 2015 Completion: Mar 31, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from NYU Langone Health

See all terminations from NYU Langone Health

Other Hyponatremia trials with similar outcome

Browse all Hyponatremia trials

A PHASE4 clinical study on Hyponatremia, this trial is terminated or withdrawn. The trial is conducted by NYU Langone Health and has accumulated 10 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotTerminated~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotTerminated~Jun 2018 – ~Jun 2019 · 12 months · monthly snapshotTerminated~Jun 2019 – ~Jan 2021 · 19 months · monthly snapshotTerminated~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotTerminated~Dec 2021 – ~Dec 2022 · 12 months · monthly snapshotTerminated~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotTerminated~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 23 months · monthly snapshotTerminated

Change History

10 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE4

  3. Jan 2023 — Jul 2024 [monthly]

    Terminated PHASE4

  4. Dec 2022 — Jan 2023 [monthly]

    Terminated PHASE4

  5. Dec 2021 — Dec 2022 [monthly]

    Terminated PHASE4

▶ Show 5 earlier versions

  1. Jan 2021 — Dec 2021 [monthly]

    Terminated PHASE4

  2. Jun 2019 — Jan 2021 [monthly]

    Terminated PHASE4

  3. Jun 2018 — Jun 2019 [monthly]

    Terminated PHASE4

  4. Feb 2017 — Jun 2018 [monthly]

    Terminated PHASE4

  5. Jan 2017 — Feb 2017 [monthly]

    Terminated PHASE4

    First recorded

Mar 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • NYU Langone Health
  • Otsuka America Pharmaceutical
Data source: NYU Langone Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations